Form 4 for KURA Kura Oncology, Inc.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001209191-23-011283 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-16 | KURA | DALE STEPHEN | Chief Medical Off | A - Grant | $0.00 | +23.1K | 50.8K | +84% | $0 |
| D | 2023-02-21 | 2023-02-16 | KURA | DALE STEPHEN | Chief Medical Off | A - Grant | $0.00 | +185.0K | 185.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | A | A | 23,125 | $0.00 | 50,800 | D | — | — | (F1) Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27. |
| 2 | Derivative | Option to purchase common stock | 2023-02-16 | A | A | 185,000 | $0.00 | 185,000 | D | $11.99 · — to 2033-02-15 | 185,000 Common Stock | (F2) This option vests in 48 equal monthly installments commencing on the grant date. |